APA

AlHilli M. M., Becker M. A., Weroha S. J., Flatten K. S., Hurley R. M., Harrell M. I., Oberg A. L., Maurer M. J., Hawthorne K. M., Hou X., Harrington S. C., McKinstry S., Meng X. W., Wilcoxen K. M., Kalli K. R., Swisher E. M., Kaufmann S. H. & Haluska P. (20170512). In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma. : Gynecologic oncology.

Chicago

AlHilli Mariam M, Becker Marc A, Weroha S John, Flatten Karen S, Hurley Rachel M, Harrell Maria I, Oberg Ann L, Maurer Matt J, Hawthorne Kieran M, Hou Xiaonan, Harrington Sean C, McKinstry Sarah, Meng X Wei, Wilcoxen Keith M, Kalli Kimberly R, Swisher Elizabeth M, Kaufmann Scott H and Haluska Paul. 20170512. In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma. : Gynecologic oncology.

Harvard

AlHilli M. M., Becker M. A., Weroha S. J., Flatten K. S., Hurley R. M., Harrell M. I., Oberg A. L., Maurer M. J., Hawthorne K. M., Hou X., Harrington S. C., McKinstry S., Meng X. W., Wilcoxen K. M., Kalli K. R., Swisher E. M., Kaufmann S. H. and Haluska P. (20170512). In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma. : Gynecologic oncology.

MLA

AlHilli Mariam M, Becker Marc A, Weroha S John, Flatten Karen S, Hurley Rachel M, Harrell Maria I, Oberg Ann L, Maurer Matt J, Hawthorne Kieran M, Hou Xiaonan, Harrington Sean C, McKinstry Sarah, Meng X Wei, Wilcoxen Keith M, Kalli Kimberly R, Swisher Elizabeth M, Kaufmann Scott H and Haluska Paul. In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma. : Gynecologic oncology. 20170512.